It is the intent of the Legislature to encourage research on the effectiveness of RU-486 (mifepristone) in treating breast and ovarian cancer, meningioma, endometriosis, Cushing’s syndrome, osteoporosis, diabetes, and AIDS.
(Added by Stats. 1991, Ch. 792, Sec. 1.)
Last modified: October 25, 2018